Clinical Trials Directory

Trials / Completed

CompletedNCT03232528

The Promotion Plan of Moxibustion on Ulcerate Colitis

A Study on the Promotion Plan of the Moxibustion Treatment of Ulcerate Colitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Shanghai Institute of Acupuncture, Moxibustion and Meridian · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

To evaluate the efficacy of Moxibustion in the treatment of Ulcerative Colitis, thus the scientific foundation for rational use of Moxibustion in clinical usage, in order to find admission of the Acupuncture and Moxibustion and even medicine field, accomplish popularization and application.

Detailed description

A total of 128 patients with UC were randomly divided into the following 2 groups: a) Herb-partition moxibustion (Treatment Group) and b) Sham herb-partition moxibustion (Control Group). All patients in the trial will be treated with moxibustion 3 times a week, once a day for 30 minutes, for a total of 12 weeks. After treating the treatment had ended and the 52nd week of follow-up to observe the clinical therapy effect of Moxibustion in UC patients. Tissue morphology and molecular biology tests will be conducted to observe the regulation in the intestinal mucosa of UC patients. All these steps will be done in order to provide clinical usage for the effects of herb-partition moxibustion in the treatment of UC.

Conditions

Interventions

TypeNameDescription
OTHERHerb-partitioned moxibustionPatients receive herb-partition moxibustion 3 times a week, once a day for 30 minutes, for a total of 12 weeks.
OTHERSham herb-partitioned moxibustionPatients receive sham herb-partition moxibustion 3 times a week, once a day for 30 minutes, for a total of 12 weeks.

Timeline

Start date
2016-11-01
Primary completion
2018-12-30
Completion
2019-12-30
First posted
2017-07-28
Last updated
2021-03-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03232528. Inclusion in this directory is not an endorsement.